However, considering the lack of expression of HSD11B1 and CBR1 in human hepatoma cells, the potential contribution of these enzymes in cortisone metabolism, resulting in differences in the proportion of the 5β-reduced product, may be small, but cannot be excluded. The gene discussed is HSD11B1; the disease is hepatocellular carcinoma.